User contributions for JDoerfler
Appearance
22 July 2024
- 10:0110:01, 22 July 2024 diff hist +2,510 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 09:4109:41, 22 July 2024 diff hist +20 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 09:4009:40, 22 July 2024 diff hist +1 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 09:0009:00, 22 July 2024 diff hist +2 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 08:5108:51, 22 July 2024 diff hist −1 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 08:5108:51, 22 July 2024 diff hist +4,548 N Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial }} {{Study Note}} =Brief summary= 376 patients with different types of cancer took part in this study to investigate carnitine on tiredness/fatigue caused by cancer or the associated chemotherapy and medication. They were randomly assigned to 2 groups, one..."
- 08:4608:46, 22 July 2024 diff hist +3 Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary current
- 08:4608:46, 22 July 2024 diff hist +2,171 N Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Created page with "{{Publication |Title=L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial |Topic=Carnitine |Author=Cruciani, RA; Zhang, JJ; Manola, J; Cella, D; Ansari, B; Fisch, MJ |Year=2012 |Journal=Journal of clinical oncology: official journal of the American Society of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2011.40.2180 |Authors Abstract=Pur..."
- 08:2708:27, 22 July 2024 diff hist 0 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 08:2608:26, 22 July 2024 diff hist −1 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 08:2508:25, 22 July 2024 diff hist +4 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
19 July 2024
- 11:4211:42, 19 July 2024 diff hist +1 Togni et al. (2015): Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial No edit summary
18 July 2024
- 08:0408:04, 18 July 2024 diff hist +161 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
- 07:2607:26, 18 July 2024 diff hist +57 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
- 07:1707:17, 18 July 2024 diff hist +435 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
- 07:0307:03, 18 July 2024 diff hist +5,297 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
- 06:3306:33, 18 July 2024 diff hist 0 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
- 06:3306:33, 18 July 2024 diff hist +477 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
16 July 2024
- 14:1814:18, 16 July 2024 diff hist 0 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
- 14:1814:18, 16 July 2024 diff hist +8,191 N Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study }} {{Study Note}} =Brief summary= The study investigated the impact of carnitine on fatigue/exhaustion caused by cancer and the associated chemotherapy and medication. A total of 33 patients with various cancers and a carnitine deficiency caused by the treatment were randomly assigned to two groups. One group..."
- 13:3813:38, 16 July 2024 diff hist +2,954 N Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study Created page with "{{Publication |Title=L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study |Topic=Carnitine |Author=Cruciani, RA; Dvorkin, ED; Homel, P; Culliney, B; Malamud, S; Lapin, J; Portenoy, RK; Esteban-Cruciani, N |Year=2009 |Journal=Journal of pain and symptom management |DOI=https://doi.org/10.1016/j.jpainsymman.2008.03.021 |Authors Abstract=Carnitine deficiency is prevalent in populations with chronic i..." current
- 13:2913:29, 16 July 2024 diff hist +7 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary
- 13:2813:28, 16 July 2024 diff hist +55 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary
- 13:2513:25, 16 July 2024 diff hist −1 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary
- 13:2313:23, 16 July 2024 diff hist +2,637 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary
- 12:5612:56, 16 July 2024 diff hist +173 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary
- 11:5711:57, 16 July 2024 diff hist −1 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary
- 11:5711:57, 16 July 2024 diff hist +9,869 N Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy Created page with "{{Reference |Reference=Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy }} {{Study Note}} =Brief summary= This study investigated the effect of carnitine as an adjuvant to the usual medication (sildenafil) in erectile dysfunction following prostatectomy. Ninety-six patients participated in the study, of which 29 were in the control..."
- 10:0010:00, 16 July 2024 diff hist +2,318 N Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy Created page with "{{Publication |Title=Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy |Topic=Carnitine |Author=Cavallini, G; Modenini, F; Vitali, G; Koverech, A |Year=2005 |Journal=Urology |DOI=https://doi.org/10.1016/j.urology.2005.05.014 |Authors Abstract=Objectives To determine whether propionyl-l-carnitine (PLC) plus acetyl-l-carnitine (ALC) improves the e..." current
- 09:3709:37, 16 July 2024 diff hist +202 Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients No edit summary
- 09:3309:33, 16 July 2024 diff hist +1,787 Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients No edit summary
- 09:1309:13, 16 July 2024 diff hist 0 Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients No edit summary
- 09:1209:12, 16 July 2024 diff hist −1 Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients No edit summary
- 09:1209:12, 16 July 2024 diff hist +11,285 N Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients Created page with "{{Reference |Reference=Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients }} {{Study Note}} =Brief summary= =Study Design= In this study, breast cancer patients were examined during radiotherapy, with one half taking curcumin alongside radiotherapy and the other half taking a placebo. In the curcumin group, the severity of radiodermatitis (a common skin disease associated with ra..."
- 08:2508:25, 16 July 2024 diff hist +5 Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer No edit summary
- 07:2207:22, 16 July 2024 diff hist +1,743 N Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients Created page with "{{Publication |Title=Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients |Topic=Curcumin |Author=Ryan, JL; Heckler, CE; Ling, M; Katz, A; Williams, JP; Pentland, AP; Morrow, GR |Year=2013 |Journal=Journal of Radiation Research |DOI=https://doi.org/10.1667/RR3255.1 |Authors Abstract=Radiation dermatitis occurs in approximately 95% of patients receiving radiotherapy (RT) for breast cancer. We con..." current
15 July 2024
- 14:1814:18, 15 July 2024 diff hist −1 Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study No edit summary
- 14:1814:18, 15 July 2024 diff hist +7,283 N Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study Created page with "{{Reference |Reference=Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study }} {{Study Note}} =Brief summary= This study investigated the efficacy of a curcumin mouth rinse compared to a povidone-iodine mouth rinse in patients with head and neck cancer during radiotherapy. Throughout radiotherapy, mucositis (an inflammation of the mucosa, a common a..."
- 13:4713:47, 15 July 2024 diff hist +2 Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study No edit summary current
- 13:4713:47, 15 July 2024 diff hist 0 Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study No edit summary
- 13:4713:47, 15 July 2024 diff hist +2,379 N Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study Created page with "{{Publication |Title=The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study |Topic=Curcumin |Author=Rao, S; Dinkar, C; Vaishnav, LK; Rao, P; Rai, MP; Fayad, R; Baliga, MS |Year=2014 |Journal=Integrative Cancer Therapies |DOI=https://doi.org/10.1177/1534735413503549 |Authors Abstract=Purpose. Radiation-induced oral mucositis is an acute morbidity seen in patients u..."
- 13:2913:29, 15 July 2024 diff hist +732 Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer No edit summary
- 13:2513:25, 15 July 2024 diff hist +3,639 Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer No edit summary
- 13:1513:15, 15 July 2024 diff hist +4,955 N Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer Created page with "{{Reference |Reference=Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were examined during radiotherapy. The patients were instructed to apply a gel to the entire oral cavity 3 times a day, with half receiving a curcumin gel and the other half a placebo gel. There were more cases of severe mucositis (an inf..."
- 13:0913:09, 15 July 2024 diff hist +1,889 N Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer Created page with "{{Publication |Title=The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer |Topic=Curcumin |Author=Mansourian, A; Amanlou, M; Shirazian, Sh; Moosavian Jahromi, Z; Amirian, A |Year=2015 |Journal=International Journal of Radiation Research |DOI=https://doi.org/10.7508/ijrr.2015.03.011 |Authors Abstract=Background: Different treatment and protective approaches for radiation-induced oral mucositis have been pract..."
- 12:4512:45, 15 July 2024 diff hist +494 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 12:4412:44, 15 July 2024 diff hist +826 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 12:4312:43, 15 July 2024 diff hist +1,270 Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study No edit summary
- 12:3912:39, 15 July 2024 diff hist +746 Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study No edit summary
- 12:3412:34, 15 July 2024 diff hist 0 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary